CHARL.RIV.LAB INTL DL-,01
CHARL.RIV.LAB INTL DL-,01/ US1598641074 /
RV6
|
14/11/2024 08:11:59
|
Chg.
-7.30
|
Volume |
Bid20:04:59 |
Demandez à20:04:59 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
194.50EUR
|
-3.62%
|
0
Chiffrre d'affaires: 0.00 |
-Bid taille: - |
-Ask la taille: - |
9.57 Mrd.EUR |
- |
- |
Description de l'entreprise
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Its employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.
Conseil d'administration & Conseil de surveillance
| PDG |
| James C. Foster |
| Conseil d'administration |
| Flavia Pease, William D. Barbo, Victoria L. Creamer, Birgit Girshick, Joseph W. LaPlume, Shannon M. Parisotto, Brian Bathgate, Ph.D., Matthew L. Daniel, Kerstin Dolph, Colin S. Dunn, Ph.D., Kristen M. Eisenhauer, Professor Julie Frearson, Ph.D., Wilbert Frieling, D.V.M., E.R.T., John C. Ho, M.D., Foster T. Jordan, Michael G. Knell, Mark Mintz, Gina M. Mullane, Barbara J. Patterson |
| Conseil de surveillance |
| James C. Foster, Nancy C. Andrews M.D., Ph.D., Robert J. Bertolini, Deborah T. Kochevar, D.V.M., Ph.D., D.A.C.V.C.P., George Llado, Martin Mackay, Ph.D., George E. Massaro, C. Richard Reese, Craig B. Thompson, M.D., Richard F. Wallman, Virginia M. (Gina) Wilson |
Données de l'entreprise
| Nom: |
Charles River Laboratories International, Inc. |
| Adresse: |
251 Ballardvale Street,Wilmington, Massachusetts 01887, USA |
| Téléphone: |
+1-781-222-6000 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
www.criver.com |
| Industrie: |
Biotechnology |
| Secteur: |
Biotechnology |
| Sous-secteur: |
Biotechnology |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
88.30% |
| IPO date: |
23/06/2000 |
